Skip to main content
Premium Trial:

Request an Annual Quote

John Cooke, William Hiatt, Joseph Coll, Eric Fung

Premium
Vermillion last week said it has formed a clinical steering committee to help it develop and commercialize a blood-based test for peripheral artery disease.
 
The committee will also provide scientific guidance to help the company get approval from the US Food and Drug Administration for the test under development by Vermillion, the company said in a statement.
 
The initial members of the committee are: John Cooke, a professor of medicine at Stanford University and immediate past-president of the Society for Vascular Medine and Biology; William Hiatt, president of the Colorado Prevention Center and professor of medicine and chief of vascular medicine at the University of Colorado Denver School of Medicine; Joseph Coll, senior biostatistician at the Colorado Prevention Center and assistant professor at the University of Colorado Denver School of Medicine; and Eric Fung, CSO of Vermillion.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.